AboutBlogFDA EmployeeOver 40,000+ FDA inspection documents: 483s, EIRs, 483Rs

EIR Taro Pharmaceuticals U.S.A., Sep 2001

$1,190 - Available for instant download

FDA investigators audited the Taro Pharmaceuticals U.S.A. - Hawthorne , NY, United States facility and issued inspectional observation (via FDA 483) on 17 Sep 2001.

Product Details

  • Inspection end: 17 Sep 2001
  • Location: Hawthorne, United States
  • FEI: 2435212
Taro Pharmaceuticals U.S.A. FDA inspection 483 Sep 2001